Showing results (61-70 of 434) with videos related to
Sort By:
Pageof 44
Frontiers in Psychology|June 16, 2015
Greater decision-making competence is associated with greater expected-value sensitivity, but not overall risk taking: an examination of concurrent validityAndrew M Parker, Joshua A WellerJournal of Behavioral Decision Making|October 14, 2014
Identifying the Effects of Unjustified Confidence versus Overconfidence: Lessons Learned from Two Analytic MethodsAndrew M Parker, Eric R StoneJournal of Addiction Medicine|October 3, 2023
Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US StatesPaul J Joudrey, Kevin Chen, Benjamin J Oldfield, et al.The Lancet. Public Health|December 19, 2017
Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people who inject drugs: a cost-effectiveness modelling studyJennifer Uyei, David A Fiellin, Marianne Buchelli, et al.Addictive Behaviors|January 29, 2010
Unobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trialErik W Gunderson, Xin-Qun Wang, David A Fiellin, et al.Journal of General Internal Medicine|January 5, 2012
Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary careBruce R Schackman, Jared A Leff, Daniel Polsky, et al.Disease Management : DM|June 22, 2005
Primary intensive care: pilot study of a primary care-based intervention for high-utilizing patientsKaren E Brown, Jeffrey M Levine, David A Fiellin, et al.Addiction (Abingdon, England)|February 23, 2016
Estimating demand for primary care-based treatment for substance and alcohol use disordersColleen L Barry, Andrew J Epstein, David A Fiellin, et al.Journal of Substance Use and Addiction Treatment|June 10, 2024
Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trialDylan Rose Balter, Lisa B Puglisi, James Dziura, et al.Journal of Addiction Medicine|October 3, 2023
Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards SurveysKevin Chen, Benjamin J Oldfield, Paul J Joudrey, et al.Pageof 44